Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
Read transcripts of webcasts and audiocasts
Read transcripts of webcasts and audiocasts
Disclaimer: This is a machine-generated transcript and may contain inaccuracies.
Good morning, everyone, and welcome to our second quarter results presentation. Joining me today, I have our CFO, Thomas Bergdoll. And we also have Tim Stevenson, our president of global sourcing and trading, as well as sustainability. With that, let's head into slide number two. This is what we will cover today. We will run through our quarterly highlights, some select events. We'll do a business and financial update, including a progress update on EUDR Compliance from my colleague Tim, and then some concluding remarks from myself. And we will also have a Q&A session at the end. So save your questions for that on slide three, just very shortly. Regarding forward-looking statements, this presentation includes forward-looking statements that come with risks and uncertainties. These are our views on future events and financial performance. But actual results could be different. So please keep that in mind when digesting the material. With that, page number four. And some comments on our key financials for the second quarter of 2024. In Q2, our volumes grew by 4%, driven mainly by chocolate and confectionery fats and food ingredients. Our operating profit per kilo increased by 21% at fixed currencies, mainly driven by our global optimization programs and operational leverage from higher volumes. Profitability was also supported by continued favorable market conditions. Overall, operating profit increased by 26% at fixed currencies. Operating cash flow was solid, even with increased working capital due to the higher volumes that we are seeing. Our leverage remains low at 0.41 in net debt to EBITDA, and our return on capital employed was strong at 21.5%. Please turn to the next page. Page five. We had our AGM or Annual General Meeting on May 8th in Sweden with good representation, 77% of the shareholders represented. We are now up and running with our bio-boilers at the Aarhus site in Denmark, and we're nearing full capacity. And this helps us to reduce our CO2 emissions from this plant by over 90%. And it's also saving us 100 million annually in cost savings. So, really good projects there that are now up and running. With that, please turn to page number six. Comments on our business area. Starting with food ingredients, we grew our volumes. They increased by 4%, driven by bakery and dairy while special nutrition declined. Operating profit per kilo increased by 15% thanks to continued optimization and portfolio management. From an industry perspective, it was primarily driven by dairy, special nutrition, and food service. And with that, our operating profit, all in all, rose by 19% and reached SEK 756 million despite a 3 million negative currency effect, moving on to chocolate and confectionery fats on slide seven. Our volumes increased by 14%, building on last year's soft second-quarter performance, and it was further supported by favorable market conditions. So really a strong volume growth. Our operating profit per kilo increased to 3.55, with a 0.1 per kilo positive currency impact. And that all in all, led to an operating profit that reached 433 million SEK and increased by 58% versus last year. And that was driven by further optimization of the CCF portfolio. Good leverage on increased volume as well as increased market penetration with our alternatives to conventional products. With that, let's move to page eight. Technical products and feed volumes declined 11% in the quarter. This decline was due to production challenges during the restart process following our annual unplanned maintenance stop. So really an isolated event with a longer stop than anticipated. As a result, production remained offline longer than anticipated. Adjusted for this one-off stop, volumes in technical products and feed actually grew by 3%, and operating profit per kilo, of course, was negatively impacted by the low volume following the longer than normal stop that we experienced, thus operating profit per kilo dropped to 6.15 and the overall operating profit fell to 9 million SEK, a decrease by 80%. But again, very much linked to a longer than normal stop. Production did come back up and has returned to normal. With that, I hand it over to you, Tim, for an update on EUDR Compliance and what we are doing.
Thank who Johan and good morning, everybody. Please turn to slide nine, which deals with progress on deforestation-related targets. First, some context from our sustainability report for 2023. You can see that up to 2023, we have made excellent progress towards our target of having 100% deforestation-free sourcing of palm oil by the end of 2025, and it's at 83%. And on traceability to the plantation, which is at 93% in 2023. We are also now making progress in planning to meet our science-based targets for 2030, which were accepted by the Science-Based Targets Initiative (SBTi) in December last year and which comprise various targets in relation to carbon emissions. This is all very good news and demonstrates the positive impact which AAK can and does make being one of our key aspirations for 2030. Please don't move on until the next slide; slide ten deals with several actions to meet EU compliance. The EU Deforestation Regulation, enforced since mid-2023, provides mandates for traceability and deforestation for commodities placed on the EU market, including palm oil, soy, cocoa, copper, coffee, rubber, cattle, and timber starting from December 30, 2024. So this year, all imported raw materials in these categories must comply with EU requirements, including evidence of traceability to source, proof of legal production, and being deforestation-free since 2020. For AAK, this impacts palm and soy in particular, and they have reduced their imports into the EU. It's a regulation already in force, and although there is speculation that its application may be delayed beyond the end of this year. It is a regulation with which we are planning and expecting to comply, in line with the timeline of 30th of December. We've already taken steps to comply, including working with suppliers, revising our make or buy strategy, and preparing our production setup for increased processing in Europe. We're also maintaining an open dialogue with stakeholders, underlining IT systems and documentation requirements with customers and authorities, as far as those requirements are already known. There do remain some gaps which we expect to be filled and need to be filled by the EU Commission and Member States in order to allow a smooth transition. We're working with suppliers to meet EU requirements by year end, and strategically replacing elements in our supply chain to safeguard compliance. We're also adjusting our sourcing strategies and increasing production flexibility in Europe to mitigate risks. Our 2024 capital expenditure includes 100 million SEK for upgrading European fractionation facilities and to ease compliance with other EU standards. And we're investing in expanding our presence in the port of Rotterdam and integrating IT systems for raw material traceability requirements. These investments represent early steps in our careful approach to further compliance. And with that overview, I'll hand back to Johan.
Thank you so much, Tim, for that clarification. As mentioned by Tim, we are indeed allocating some 100 million SEK to upgrade our facilities in Europe for compliance. We've also invested a similar amount to enhance our presence in Rotterdam, as you just mentioned. And we're also integrating a new IT system. And these investments really mark our initial steps to cautiously monitor regional EUDR implementation and enforcement. And we are consistently and continuously assessing potential future CapEx in order to comply and develop AAK. And with that, let's move into further comments on our financials with you, Tomas. Thank you.
Johan. Good morning everyone. Turning to slide 11. As you can see from the graph, cash flow in the quarter was driven by earnings, primarily offset by changes in our inventory mix with a higher share of palm versus shea and rapeseed. Mainly driven by seasonality, and growth in our CF business. Overall inventory levels remained stable, as did accounts receivable. And cash flow from accounts payable had a positive impact also driven by the change in inventory mix. Building on Tim's earlier comments, in order to ensure a smooth implementation of the EUDR regulation, as well as the effect of seasonal procurement of inventory related to shea and rapeseed. We will have a temporary stock buildup which is expected, all else equal, to have a negative cash flow impact of roughly 500 million SEK in the second half of the year, primarily in the fourth quarter. This effect will then reverse and return to normal over the first half of 2025. This is a regular seasonal effect, but this year is exaggerated by the EUDR implementation and the other part of the buildup is there to manage existing uncertainties that still remain in relation to the implementation of the regulation. CapEx amounts to just over 300 million SEK in the quarter. 570 million SEK year to date, and we continue to guide the 2024 full year number to 1.2 billion SEK. Next slide please. Our return on capital employed increased. No one mentioned, following the continued strong development of operating profit. With the rolling EBITDA and the calculation of roughly 4.7 billion SEK, the return on capital employed is 21.5%, and capital employed in the calculation is done at 21.6 billion SEK. And the latter remaining very stable over the last few quarters. Next slide please. When we look at our net debt to EBITDA, it remains at low levels. 0.41 in the second quarter, marginally higher than in Q1. But this is also following the dividend payout of 960 million SEK in May Q2. With that, I'll hand it back to Johan for some concluding remarks before we open up for questions.
Thank were you, Thomas. And please then turn to the next page. Slide 14. Let me just summarize the key messages here today. We are pleased with our continued progress towards our 2030 aspirations. We delivered year-on-year volume growth, organic volume growth and maintained an operating profit per kilo above two SEK, resulting in a 27% increase in operating profit. We remain focused on achieving an average operating profit growth of 10% over time, and we are prudently optimistic about the future. And with that, we would like to open up for questions. So operator, please go ahead.
If you wish to ask a question, please dial Pound Key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from Alex Jones from Buffett. Please go ahead.
Thank you for taking.
My questions are, two if I can. The first on the food ingredients margin in particular. And the sequential development, I think EBITDA per kilo is down 4%, versus Q1, while volumes are slightly up quarter-on-quarter. So, can you explain what's driving that sequential movement and whether we should expect further sequential deterioration into the second half or whether it's something that's specific to Q2? And then the second question, just on chocolate, clearly very strong volume growth this quarter. Can you talk a little bit about how much benefit you think you are already seeing from customers shifting recipes in response to the higher cocoa price, and how your pipeline of such reformulation opportunities is evolving into H2, and whether that sort of eventual opportunities much bigger than we're already seeing in the results today? Thank you.
Thank you. First of all, with regards to sequential development, there's not a big drama. There are always movements between quarters and Q2 is typically a slightly softer quarter. But I do understand the question with regards to volume sequentially. But we don't see major shifts. However, there are always some movements between, in the mix, and the portfolio, and also between certain regions. So, not a significant shift there. With regards to EBITDA per kilo development. All in all, with regards to chocolate and confectionery, this is of course, you know, we need to look at this in the total perspective. There is no doubt that, I mean, if we offer alternatives to cocoa butter, as you know, these alternatives bring functionality. It also brings cost-efficient solutions to our customers. So, with the higher cocoa price. There's certainly an interest in looking at alternatives. And we've seen that. And we comment in our report that we see an increased penetration for cocoa butter alternatives, whether a customer used to cocoa butter alternatives using more of it, or a customer that hasn't used it before is now using it, or even certain segments of customers that are really trying it for the first time. And now, replacing cocoa butter. So, that is a clear trend that we have noticed with regards to the direct link to cocoa price, it's important to keep in mind that we're always selling this in the market. There are competitors out there. You only win business based on what you offer and the value that you bring. And the total mix of why we are performing well is still back to, you know, higher volumes, which is certainly linked to market dynamics, but also that we continuously optimize our operations, our portfolio management, and the value that we bring to our customers. So, the total of that is what leads to our earnings and earnings growth.
Great. I think if I can just follow up on that a bit more, I suppose, last quarter we talked about this high cocoa price creating that interest. But you also talked about the fact it takes customers time to change their recipes. Have a lot of them now had enough time, or do you still think for many of your customers, you know, it's going to take longer? Therefore, there's more potential benefit to come if, as you say, you can outcompete your competition to win that business.
Yeah.
Great question. It does take time for reformulating, and in food and many other industries, Obviously, the consumer product companies always want to be very careful on testing things out. Within the chocolate and confectionery business, there is also a bit of, you know, yearly tenders and planning ahead. So we have seen some impact of this. And that's what we mentioned structurally. I do think that there is a real opportunity for cocoa butter alternatives going forward that we haven't seen yet. And I do believe that when customers do reformulate and see the benefits, both from a functional perspective and a cost perspective, and have proven that in their product to consumers, Then there it becomes a bit of a stickiness to it because then you are in the recipe. So we're quite positive with that regard. And then we'll keep highlighting that. I think there are even more opportunities down the line if, uh, certain countries or, uh, government bodies challenge the restriction on using cocoa butter alternatives, which in many places are kept to only 5% on the ingredient list. But, uh, we could, with good functionality, go higher.
Thank you.
The next question comes from Alex Sloane from Barclays. Please go ahead.
Good morning all. Thanks for taking the questions. Um, I've got a few questions. The first one just actually builds on the last discussion about the CBS. Um, so would you agree that there is a structural volume opportunity from increased penetration? Um, does the high cocoa butter price also grant you the opportunity to raise your pricing on KPIs in 2025? And where are we on the, uh, the sweet spot? Uh, on that, um, the second question pertains to the group more broadly; I mean, historically, the average returns on capital employed have been very favorable, driven by the margin uplift that you've delivered over the last couple of years. I mean, that's also been somewhat visible at competitors like Bunge and Fuji Oil over the past year or two. So, you know, I wonder, do you think the high return on invested capital that the industry is achieving is structurally sustainable in vegetable oil processing, or, specifically in segments like CVS, could strong developments potentially encourage more capacity from larger competitors over the medium term? That would be the second question. And then just finally, Tim, thanks very much for the detail on the EU. Um, it's great to hear that you're making progress there. <th /> Uh, obviously, you know, last year there was an investigative piece in Sweden, on Nature, that linked AAK and others to buying from mills in Indonesia that, you know, have been linked to palm fruit from protected lands. Um, I wonder, are you confident that the traceability that you now have in place to the plantation would have prevented that? Thanks very much.
Thank, uh, great question starting then with, uh, CBE and whether that would be a license to raise prices. I think this needs to be repeated. Right, we always win and lose against competition, and there's always price negotiations. So I don't necessarily think I would call it a license to raise prices. However, we can all understand that if there is an increased demand and increased opportunity, uh, you know, that demand pull is also playing into the industry dynamics and the competitive landscape. So with that, uh, of course, these dynamics are supportive in terms of, of continuing to focus on, on good alternatives to cocoa. Um, then with regards to, you know, is the higher return sustainable and so forth with regards to the total orders and fats. I, you know, from my point of view, have been quite vocal about this, and in certain contexts, we are a multi-oil ingredient house as AAK, and we compete against other oil ingredient players, some of them vertically integrated. Some would call it, you know, a commodity type setup. But these are ingredients we sell. And if you look at the profitability, if you look at the EBIT that we have as an industry, it's a quite low EBIT type industry. So I think there is a huge opportunity to make sure that any ingredient is sold based on the risks we're taking, the value that we bring. And in that context, I do believe that higher margins for companies producing fat ingredients, which play a huge role in end product quality, taste, and texture, make sense to have good returns, you know, and I think that is where I leave it internally. We do have continued opportunities for optimization, alignment across our industry, driving portfolio management, and learning from food ingredients into chocolate and confection and vice versa, and also leveraging opportunities in replacing fossil-based ingredients within technical products and feed. There are huge opportunities, I think, to drive value. And if you have further comments to that, Thomas?
No, I think the improvements that you've seen in 2022 and 2023 now continue in 2024. As we've stated before, we see the majority of that being driven by internal changes we've made and efficiency gains and so forth. Right. Getting up to a more reasonable level of profitability for a business like ours as we see it, as Johan said, providing functional ingredients into the food industry.
Yes.
And then the last question here on traceability. Great question. It's important that we drive fully sustainable supply chains. Polymer is such an important product for feeding the world and ensuring traceability. Stopping deforestation is key for us and key for the world. But Tim, do you have specific answers to this question?
Sure.
Alex, yeah. I mean, in relation to the issue. One issue that you raised, that was brought forward by 'Swedish Nature' last year, our traceability, as we've already said, up to the plantation in 2023, was 93%. So not 100% yet. And even if it was 100%, then I think we can't rule out individual issues arising. It's a bit like health and safety. You never want them to arise, but sometimes you get them, and then it's important as to how you react to those sort of issues when they do arise. And so I think that we are confident that our ability to manage plantation is appropriate to what we do. It's actually quite different from the EU requirements as well. It's perhaps important to say that the EU requirements are about compliance and providing polygons for each individual location from where we source. So, that is a difference, as our focus is more on the sustainability side and making sure that we contribute to sustainability. And I am recognized for doing that. So I can't give you absolute confidence that we won't encounter anything else that arises, of course, because some things do come out from time to time. But I think our level of traceability and our actions in that area are appropriate and industry-leading, in fact.
Yes, we are actively driving it as a positive force for sustainability in all these areas. So, I'm confident that we are doing the right thing, but there's never a guarantee against someone misplacing things in a certain situation.
Very clear. Thank you.
The next question comes from Priya Patel from UBS. Please go ahead.
Hi. Congratulations on the results today. I have two main questions. So firstly, within food ingredients. I'm just digging into sub-segments. The bakery grew volumes year-over-year. But the EBIT per kilo development was flat. Was this due to mix or price-to-raw-material spread? And then also, for special nutrition, volumes declined year-over-year. But you saw EBIT per kilo grow. Could you again just explain the dynamics here, please?
Thank you for the question. As Johan mentioned earlier in Food Ingredients, there is some seasonality affecting Q2, as we mentioned before. So, no major items that stand out for us in the quarter. The margins and the volumes will fluctuate somewhat. When we look at special nutrition, as mentioned over the last couple of years, we face challenges on the volume side, particularly with high-end products going into the Chinese market, primarily driven by the reduction in birthrates. That trend continues. However, the margin has improved somewhat over time, which is nice to see. And that's also connected, as we mentioned before, to some of the raw material prices. But the pressure on special nutrition in terms of volumes continues. Yes.
So, all in all, we focus on these optimization programs, portfolio optimization. We are also present in the market within the competitive landscape. So, back to the bakery. Of course, in some cases, we accept a bit of volume reduction on a lower margin. But we focus on higher margin businesses. So looking at the total portfolio, as you can see, we're up. We're leveraging high volumes. However, there will be dynamics between segments from quarter to quarter.
And sequentially in food ingredients. We also see our food service business growing. And they tend to bring margins that are slightly lower than average into the business. So this also has an effect.
We've seen a good year-on-year EBITDA improvement, but it is slightly diluted when extended over another year.
These are the dynamics.
Okay, thank you.
The next question comes from Joan Lim from BNP Paribas Exane. Please go ahead.
Hello.
Thanks for taking my questions. I have two, please. So, just picking up on the food ingredients point. Other than optimization, I think EBITDA has been strong partly due to your strategy to improve the product mix. Can you share more about what are some of the drivers of growth and premiumization within this segment, excluding special nutrition? That's my first bromethalin poisoning. And my second question is about CCF. How far is there to go on this reformulation opportunity? You mentioned there's annual contracting. How should we think about the second half of the year? Is it going to continue? Will the strength we are seeing so far continue or can we expect some deceleration? Thank you.
Thank you. Well spotted. Speaking about the optimization and portfolio management that we have implemented within the food ingredients sector, excluding special nutrition, you know, we have large volumes in both bakery and dairy. We've implemented effective programs running with a structured process. We call it a factory deep dive, where we analyze a complete factory setup, examining how we run it, how we plan it, and what the profitability is by product category, and then aim to optimize. This could involve internal improvements on how we plan production to save costs. It might also involve challenging products with lower profit margins. And I mean, that method and that concept work in any segment, any industry. Right. So, we have seen benefits in that. Furthermore, our focus is on high-value-added ingredients, really specialized ingredients. And within all the industries that we serve, particularly dairy, bakery, as well as special nutrition, chocolate, and confectionery, there are pockets of opportunities where our functional ingredients really play a different, beneficial role in terms of the recipe for our customers. So it's been a focus within dairy, bakery, food ingredients, and also within food service to really optimize the portfolio, delivering high-value-added products. And with that drive, call it a better mix or at least a better EBITDA per kilo. So, if that helps answer the question there on food ingredients, then I'm moving over to continued strength. Please repeat the question on the second quarter. Although, was that the second half of the year being discussed?
Yes, in the CV reformulation opportunity because contracts are annual. Right. So just trying to get a sense of H2.
Yeah. Thank, you. I just needed that reminder as well. Yes. With regards to CCF in total. Right. Let's keep in mind, when we speak about the performance in chocolate and confectionery fats, we bring a broad portfolio of solutions within that industry offering, be it CBS or other alternatives to cocoa butter, including filling fats and so forth. In total, these alternatives replace cocoa butter in one way or another in different confectionery applications. CB being a dominant one that really is a cocoa butter equivalent. So, the total portfolio does deliver a cost-efficient value to our customers. When we look at this from an industry and a yearly cycle perspective, the large players in these industries, the large consumer goods companies, often do yearly tenders where we offer our ingredients at a price and so forth, and then we get an allocation, but you typically don't allocate your full volume. So during the year there will typically be opportunities to win business over time. So, therefore, as we look into the second half of the year, a lot of it has been contracted already back in the third and fourth quarters of last year, but some are still there to be contracted. You know, during the first half of this year and even now during the third quarter into the late third and fourth quarters, and then we will come into the allocation contracting season again at the end of the third and fourth quarters for 2025. So that's the kind of dynamics we're observing. And some of these dynamics in the industry linked to cocoa prices and so forth have really accelerated towards the end of last year and the beginning of this year. So I think we're far from seeing the full impact of that. But we have seen some of it.
Okay. Thank you. That's really helpful. Um, may I just squeeze in one more question? So on finance costs, they have remained high even though they've come down year over year due to your reduced debt levels. Um, can you just remind us what's driving these higher finance costs this year?
Thomas.
Thank you for the question. I think if you look at the financing costs, the interest rates have come up over the last couple of quarters, as you've seen. Now we see about 60,000,000 in the second quarter, on average, in financing la costs. So it has remained fairly stable. The cash flow includes, among other items, taxes. There is a seasonality to that, where we pay more taxes from a liquidity standpoint during the Q2 period compared to other periods in the year. So that's part of it, at least a liquidity effect to it.
Um, are there any hyperinflationary considerations in finance costs because, previously, I think there was an earthquake in Turkey? Uh.
There is a little bit of impact. The impact in Q2 was very limited and primarily related to Turkey, which is still under the hyperinflation definition from an accounting perspective, but it did not have a significant impact on the quarter.
Okay.
Thank you.
The next question comes from Benjamin Wannstedt from ABG Sundal Collier. Good morning, everyone, and welcome to AAK's Interim Q2 2024 webcast presentation.
Good morning. A couple of follow-ups on previous questions with higher prices for cocoa, and thereby also for chocolate. What is your view of volume growth in the chocolate market overall going forward? Do you get any indications from customers in this regard, please? That would be interesting.
Yes, thank you. And of course, that's the end consumer demand. We're talking about the absolute volume growth. We haven't seen a lot of impacts yet. So, kind of small movements in the market. As you can see, our volume growth is higher than the market. And that's linked to the topics we've already discussed. Technically, I think it's worth considering that, of course, if you see high inflation, I mean, if costs really go up and up and up, and that impacts the price on the shelf, then of course that has an impact on consumer demand. We haven't seen a huge impact yet currently. You know, low single-digit minuses. So far, all is good in terms of consumer demand still being present. We're still using indulgence to treat ourselves. And that has been the case many times during ups and downs in the industry. I am confident that we have a great opportunity to work with this opportunity for penetration in our solutions. But it's hard to say whether we will see further, more significant changes in market demand so far. It hasn't been there.
Perfect. Thank you very much. And perhaps a follow-up on this one. On the previous question, I get a few questions about obesity-related medication possibly having a negative impact on volume growth for products such as chocolates. Do you see any difference in consumer demand between North America, where the penetration of such medications is higher than in Europe, for example?
No, a simple answer is no. Absolutely not, not yet. Maybe would be the prudent answer. But these are medicines that potentially can help us have better health and so forth. And our view at the moment is that it's great to focus on health and the possibility for us to live longer when we look at the sustainability challenges that we have, which need to impact our diet. So I think there's a huge opportunity in the future for a growing population that might live longer, even with the help of such medicines. But also, there's a greater need for plant-based ingredients to shift diets from animal-based and also from shifting away from fossil-based in other sectors. So when we look at this, we do see a strong future for plant-based oils and fats. But there might be some impact from medicines like that. But that's where we stand at the moment. We haven't seen anything in the demand picture at all.
Perfect. Thank you very much. And then a final one from me, you gave us an adjusted volume growth figure for technical products and feeds. After the unplanned production stop, is it possible to give an indication or discuss at least sort of like an adjusted EBITDA figure for the segment as well? Please?
Yes.
Thank you. Good question. We can give you some numbers on that. If you look at the volume for the group, we had a 4% increase that we adjust for the extra downtime on TPF. If that had run on a normal schedule, we would have been at an increase of 6% instead of 4% for the group as a whole. We saw a combination of lower volumes, meaning lower sales in the quarter, with the reduced net margin and additional costs related to the stoppage, about 35 million. So instead of EBITDA being up 27% year over year, it would have been up close to 31%, and an EBITDA per kilo. That would have been up a few, to about 15 to 16. And it's not because Feed has a higher margin EBITDA per kilo, as you know, but it's the additional cost that also contributed from the stop. Uh, in addition to the lower volume. So about 35 million in the quarter.
Perfect. Thank you very much.
Yeah, thanks.
The next question comes from Victor Hanson from Carnegie. Please go ahead.
I just wanted to thank you for taking my questions. A couple of follow-ups here. Firstly, if you could provide an update on your M&A pipeline.
Well.
I could, of course, but we don't comment specifically. Right. So let me maybe rephrase the question or the answer. An update on M&A. We obviously possess a continued strong balance sheet. Uh, we do believe that we have an opportunity to consolidate, expand geographically, acquire bolt-on assets, and if something bigger materializes. So I think the same answer to what we have said before: we are still very interested. We're still very capable. Uh, but there aren't many transactions out there in our market. So we just need to be focused, making sure that we are relevant when anything arises, and we are very willing to do so. But I can't comment on any specifics. Uh, yeah. Yeah.
Of course that's. Yeah, exactly. That's how I meant it. It seems like the amount of dialogue here is similar to before. Yeah. And the next question I had here was if you could give an update on your Cash to Grow program, which might mitigate some of the issues driven by increased working capital.
Thomas, any thoughts on that?
We, the program is continuing. Uh, we have scheduled a few more facilities and plants for upgrades during the fall. Uh, and it's progressing well. Uh, we did measure the development of working capital days between the facilities that had gone through the project and those that hadn't. And, actually, so far, there has been a seven-day reduction in working capital with the facilities where we had gone through the Cash to Grow process, compared to those that hadn't. So far, we have seen a good effect and we hope that will continue as we roll this out to the remaining plants and facilities in 2024 and continuing through 2025 as well. The progress is good, but it is quite labor intensive in each plant. Therefore, we will continue this activity into 2025.
Perfect, and perhaps the final question here concerning TPF. The lower volumes were due to the production stop. Should we expect these volumes to be delivered in Q3 instead?
Thank you. No, it was a longer stop, and we essentially lost that opportunity for production and sales. However, we are up and running as normal, so although there's no unexpected catch-up, we still expect it. Now we're back to normal operations.
Okay, perfect. That's all for me. Thank you.
But just as an additional comment, we don't see any negative effects on volume going forward from not being able to supply during that period. So it's more a hand-to-mouth type of business in that way.
Okay. Thank you.
Thank you.
All right. I think that was the last question. Or we actually have time for one more question, I think. So if there's one more question, we could take it.
The next question comes from Oskar Lindstrom from Danske Bank. Please go ahead.
Yes. Most of my questions have been answered. But I do have one question. And I guess it's for you, Tim. On the order, and if you know, can you say what kind of impact this regulation is having on the competitive landscape? Are you seeing any changes in supply to the EU, with competitors perhaps giving up on the European market, or at least segments of the market, due to tighter regulations? Yes.
Thank you, Tim.
Yes, I will ask. Well, it's not implemented yet actually. So it's a difficult question to answer as it doesn't come into effect until the end of this year. I don't expect any significant changes in terms of the competitive landscape. Really, everybody is affected in pretty much the same way, especially as far as the oils, like palm and soy, which impact us. Um, and I couldn't comment on the other commodities. It may have some sort of impact, but it would be speculative to say if it has had any yet. So, maybe ask me in six months time, and then I'll be able to give you a better answer on that. Yeah.
I mean, as is the case, we are agile. We are on top of it. We're striving to lead and be really well prepared. I think our greater concern is rather what this kind of very detailed regulation and detailed focus on compliance is doing to Europe. You've heard those voices in many areas, so it's a bit concerning that they chose a very comprehensive way of improving compliance. And with that, costs for importing goods into Europe are likely to increase and so forth. But we are on top of it and we will be able to comply as we understand more of this. And then we'll see what impact it might have on the competitive landscape. But I think the greater conversation should rather be on Europe as a whole. And these kinds of regulations, as well as the costs of compliance versus the benefits, were, as you've heard, our focus areas, for example, satellite monitoring to drive no deforestation. So we share the same objective and intent. However, the EU has chosen a more difficult path for compliance compared to our choice.
I agree with you that that seems to be the case. Have you seen any of your customers considering changing their sourcing and use of raw materials for oils and fats due to this regulation, making palm oil relatively less attractive and other oils relatively more attractive? You know, is it happening, are there any changes in demand?
Thank you. Great question. There are some examples, but they don't significantly impact the major items. So, large customers and volume products in the market, no big change. And I don't expect it to be. There are some that do look into that. And it's actually part of our plan. We are striving to comply. We're looking at reformulations. We're examining how we source and what suppliers we're using, and we're considering some internal make-buy investments, as you've heard. However, I think it's worth raising the point here. Again, that could be a simple way for someone to just not, you know, have to deal with it. Let's say you choose another oil, you reformulate, then you don't have to deal with that. Does that make deforestation lower in the world? Does that make our world more sustainable? Uh, does that mean that we mean that we would meet our targets faster, uh, on the 1.5 degrees? No, it won't, because many of the other solutions are less sustainable than a sustainable supply of palm, for example. So this is where we advocate facts on the table. Look at what ingredients, what kind of diets are more sustainable than others. But this type of regulation will have some consequences and some of them may be irrational, uh, or would not lead to the right, uh, result. Uh, but for certain customers, certain players, that could be their choice. And their AAK is great. Again, I mean, we are good at reformulating. We're good at helping our customers. We do have a multi-oil ingredient house offering. So this could be beneficial for AAK, but I'm not necessarily advocating it being the best choice for uh for feeding the world sustainably.
Great. All right. Thank delegates. Those were my questions.
There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.
Thank you so much. Thank you to everyone that has been listening in, calling in, and for your great questions. Thank you, Thomas and Tim, for, uh, this call today. I wish you all the best. Thank you.



















